Elanco Animal Health (NASDAQ:ELAN) Reaches New 12-Month Low at $27.50

Shares of Elanco Animal Health (NASDAQ:ELAN) hit a new 52-week low on Tuesday . The stock traded as low as $27.50 and last traded at $28.37, with a volume of 65411 shares changing hands. The stock had previously closed at $29.81.

ELAN has been the topic of several recent research reports. UBS Group raised shares of Elanco Animal Health from a “sell” rating to a “neutral” rating and lowered their price target for the company from $31.00 to $30.00 in a research report on Thursday, August 15th. Guggenheim initiated coverage on shares of Elanco Animal Health in a research report on Wednesday, May 22nd. They issued a “neutral” rating on the stock. Zacks Investment Research raised shares of Elanco Animal Health from a “sell” rating to a “hold” rating in a research report on Monday. Finally, BMO Capital Markets upped their target price on shares of Elanco Animal Health from $32.00 to $35.00 and gave the company a “market perform” rating in a research report on Friday, May 10th. Nine investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $33.72.

The stock’s 50-day simple moving average is $32.50 and its 200 day simple moving average is $31.88.

Elanco Animal Health (NASDAQ:ELAN) last posted its earnings results on Tuesday, August 13th. The company reported $0.28 EPS for the quarter, beating the Zacks’ consensus estimate of $0.26 by $0.02. The company had revenue of $781.60 million during the quarter, compared to analyst estimates of $781.49 million. The firm’s quarterly revenue was up 1.5% compared to the same quarter last year.

Large investors have recently modified their holdings of the business. First Allied Advisory Services Inc. purchased a new stake in Elanco Animal Health during the first quarter worth about $228,000. Kayne Anderson Rudnick Investment Management LLC increased its stake in Elanco Animal Health by 24.9% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 2,265,351 shares of the company’s stock worth $72,649,000 after purchasing an additional 451,963 shares during the period. GAM Holding AG purchased a new stake in Elanco Animal Health during the first quarter worth about $625,000. US Bancorp DE increased its stake in Elanco Animal Health by 5,654.0% during the first quarter. US Bancorp DE now owns 23,994 shares of the company’s stock worth $769,000 after purchasing an additional 23,577 shares during the period. Finally, BNP Paribas Arbitrage SA increased its stake in Elanco Animal Health by 3,753.1% during the first quarter. BNP Paribas Arbitrage SA now owns 66,504 shares of the company’s stock worth $2,133,000 after purchasing an additional 64,778 shares during the period.

About Elanco Animal Health (NASDAQ:ELAN)

There is no company description available for Elanco Animal Health Inc

Read More: What is a front-end load?

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.